Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
not feeling well; nauseous; feeling very weak; wanting to throw up; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of feeling unwell in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On 26-MAR-2025, the patient received the 2nd dose of Shingrix. On 27-MAR-2025, 1 days after receiving Shingrix, the patient experienced feeling unwell (Verbatim: not feeling well), nausea (Verbatim: nauseous), weakness (Verbatim: feeling very weak) and vomiting (Verbatim: wanting to throw up). The outcome of the feeling unwell was not resolved and the outcome of the nausea, weakness and vomiting were not reported. The reporter considered the feeling unwell, nausea, weakness and vomiting to be related to Shingrix. The company considered the feeling unwell, nausea, weakness and vomiting to be related to Shingrix. Additional Information: GSK receipt date: 31-MAR-2025 The patient received the 2nd dose of Shingrix on 26 March, but today on March 27 she woke up not feeling well feeling, very weak, very nauseous, wanting to throw up and she felt a little bit better in the middle of the day and then the evening she continued to not feel well. That's how the patient described it to the reporter. So this was from getting Shingrix again and wanted to just report it. Her age was probably close to 80 years and that was all the reporter know.